<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Научные результаты биомедицинских исследований</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413 / 2313-8955-2014-1-1-53-59</article-id><article-id pub-id-type="publisher-id">231</article-id><article-categories><subj-group subj-group-type="heading"><subject>Архив</subject></subj-group></article-categories><title-group><article-title>КЛИНИЧЕСКИЙ СЛУЧАЙ ИДИОПАТИЧЕСКОЙ ЛЁГОЧНОЙ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ У ПАЦИЕНТА С СОПУТСТВУЮЩЕЙ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА: КЛЮЧЕВЫЕ ЭТАПЫ ДИАГНОСТИКИ.</article-title><trans-title-group xml:lang="en"><trans-title>A CLINICAL CASE OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION IN PATIENT WITH COMORBID ISCHEMIC HEART DISEASE: THE KEY STAGES OF DIAGNOSIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Филоненко</surname><given-names>Марина Вячеславовна</given-names></name><name xml:lang="en"><surname>Filonenko</surname><given-names>Maryna V.</given-names></name></name-alternatives><email>filmarina@rambler.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Лопина</surname><given-names>Наталия Андреевна</given-names></name><name xml:lang="en"><surname>Lopina</surname><given-names>Natalia A.</given-names></name></name-alternatives><email>alamajor@yandex.ua</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Журавлёва</surname><given-names>Лариса Владимировна</given-names></name><name xml:lang="en"><surname>Zhuravlyova</surname><given-names>Larysa V.</given-names></name></name-alternatives><email>prof.zhuravlyova@gmail.com</email></contrib></contrib-group><pub-date pub-type="epub"><year>2014</year></pub-date><volume>1</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2014/1/selection_9.pdf" /><abstract xml:lang="ru"><p>Несмотря на прогресс, достигнутый в развитии новых направлений в диагностике и лечении, идиопатическая лёгочная артериальная гипертензия остаётся одним из наиболее тяжелых и прогностически неблагоприятных заболеваний. В статье представлен клинический случай и описан алгоритм диагностики этого редкого заболевания соответственно процессу принятия решений в клинической практике. В данном наблюдении подчеркивается необходимость широкого проведения дифференциальной диагностики в случае выраженной одышки у возрастных пациентов, особенно когда интенсивность одышки непропорциональна тяжести основного заболевания сердца или легких, и если обычная терапия не проявляет ожидаемого эффекта. Ранняя диагностика идиопатической легочной артериальной гипертензии является жизненно важной для начала современной терапии с целью улучшения качества и продолжительности жизни таких пациентов.</p></abstract><trans-abstract xml:lang="en"><p>Despite the progress achieved in the development of new directions in the diagnosis and treatment of idiopathic pulmonary arterial hypertension, it remains one of the most severe and prognostically unfavorable diseases. The article presents a clinical case and an algorithm for diagnosis of this rare disease, in respect to the decision-making in clinical practice. The present case underscores the need to consider a broad differential diagnosis for marked dyspnea in mature patients, especially when the intensity of dyspnea is out of proportion to the severity of underlying heart or lung diseases, or when symptoms fail to subside as expected in response to conventional therapy. Early diagnosis of idiopathic pulmonary arterial hypertension is vitally important for initiating modern therapy in order to improve the quality and duration of life in such patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>легочная гипертензия</kwd><kwd>недостаточность правого желудочка</kwd><kwd>катетеризация правых отделов сердца</kwd><kwd>блокаторы кальциевых каналов</kwd><kwd>современная целевая терапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pulmonary hypertension</kwd><kwd>right ventricle failure</kwd><kwd>right heart catheterization</kwd><kwd>calcium channel blockers</kwd><kwd>modern targeted therapy</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>1. &amp;nbsp;McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119:2250-2294.&amp;nbsp;&amp;nbsp;&amp;nbsp;</mixed-citation></ref><ref id="B2"><mixed-citation>2. Ghamra ZW, Dweik RA. Primary pulmonary hypertension: an overview of epidemiology and pathogenesis. Cleve Clin J Med 2003; 70 Suppl 1:2-8.&amp;nbsp;&amp;nbsp;&amp;nbsp;</mixed-citation></ref><ref id="B3"><mixed-citation>3. Deng Z, Morse JH, Slager SL, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000; 67:737-744.</mixed-citation></ref><ref id="B4"><mixed-citation>4. Thomson JR, Machado RD, Pauciulo MW, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000; 37:741-745.</mixed-citation></ref><ref id="B5"><mixed-citation>5. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:55-66.</mixed-citation></ref><ref id="B6"><mixed-citation>6. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010; 137:376-387.&amp;nbsp;&amp;nbsp;</mixed-citation></ref><ref id="B7"><mixed-citation>7. Humbert M, Sitbon O, Yaici A, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 2010; 36:549-555.</mixed-citation></ref><ref id="B8"><mixed-citation>8. Barst RJ, Gibbs JS, Ghofrani HA, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54:78-84.</mixed-citation></ref><ref id="B9"><mixed-citation>9. Heresi GA, Heresi RA, Dweik A. 2007. Pulmonary hypertension: evaluation and management. Compr Ther 33(3):150-161.</mixed-citation></ref><ref id="B10"><mixed-citation>10. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30:2493-2537.</mixed-citation></ref><ref id="B11"><mixed-citation>11. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34:1219-1263.</mixed-citation></ref><ref id="B12"><mixed-citation>12. McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation 2006; 114:1417-1431.</mixed-citation></ref><ref id="B13"><mixed-citation>13. Tonelli AR, Alnuaimat H, Mubarak K. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respir Med 2010; 104:481-496.&amp;nbsp;</mixed-citation></ref><ref id="B14"><mixed-citation>14. Rich S. Executive summary from the World Symposium on Primary Pulmonary Hypertension 1998, Evian, France. World Health Organization 1998.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;</mixed-citation></ref><ref id="B15"><mixed-citation>&amp;nbsp;</mixed-citation></ref></ref-list></back></article>